(Q38800311)

6 September 2017

NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer (English)

1 reference

6 September 2017

1 reference

Suqing Liu

1

1 reference

6 September 2017

Jing Sun

2

1 reference

6 September 2017

Bin Cai

3

1 reference

6 September 2017

Xiaowei Xi

4

1 reference

6 September 2017

Liu Yang

5

1 reference

6 September 2017

Zhenbo Zhang

6

1 reference

6 September 2017

Youji Feng

7

1 reference

6 September 2017

Yunyan Sun

8

1 reference

6 September 2017

language of work or name

1 reference

22 January 2016

1 reference

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

7

1 reference

6 September 2017

9671-9680

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-016-4848-x

6 September 2017

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Treatment goals in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

A protein interaction network for pluripotency of embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Cytoplasmic NANOG-positive stromal cells promote human cervical cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Snail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

HCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Multidrug resistance through the spectacle of P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Ultrasound microbubble-mediated delivery of the siRNAs targeting MDR1 reduces drug resistance of yolk sac carcinoma L2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-4848-X

Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade

21 January 2018

1 reference

12 December 2020

Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation

1 reference

12 December 2020

Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway

1 reference

12 December 2020

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S13277-016-4848-X

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference